We are delighted to share that ๐๐ป๐ฑ๐ถ๐ฎ๐ป ๐๐บ๐บ๐๐ป๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น๐ ๐๐ถ๐บ๐ถ๐๐ฒ๐ฑ (๐๐๐) has been honored with the prestigious ๐๐ง๐๐๐ (๐๐ฒ๐ฑ๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐ง๐ฒ๐น๐ฎ๐ป๐ด๐ฎ๐ป๐ฎ ๐๐ต๐ฎ๐บ๐ฏ๐ฒ๐ฟ๐ ๐ผ๐ณ ๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ฒ ๐ฎ๐ป๐ฑ ๐๐ป๐ฑ๐๐๐๐ฟ๐) ๐๐ ๐ฐ๐ฒ๐น๐น๐ฒ๐ป๐ฐ๐ฒ ๐๐๐ฎ๐ฟ๐ฑ ๐ฎ๐ฌ๐ฎ๐ฒ ๐ณ๐ผ๐ฟ ๐๐ ๐ฐ๐ฒ๐น๐น๐ฒ๐ป๐ฐ๐ฒ ๐ถ๐ป ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐ ๐๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป โ ๐๐ฎ๐ฟ๐ด๐ฒ ๐๐ป๐๐ฒ๐ฟ๐ฝ๐ฟ๐ถ๐๐ฒ๐.
This recognition reflects our continued commitment to advancing innovative, affordable, and impactful healthcare solutions across both human and animal health. A key recent milestone has been the development of ๐๐ป๐ฑ๐ถ๐ฎโ๐ ๐ณ๐ถ๐ฟ๐๐ ๐ฎ๐ป๐ฑ ๐ผ๐ป๐น๐ ๐ถ๐ป๐ฑ๐ถ๐ด๐ฒ๐ป๐ผ๐๐๐น๐ ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐ฒ๐ฑ ๐๐ฒ๐ฝ๐ฎ๐๐ถ๐๐ถ๐ ๐ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ, contributing to the nationโs self-reliance in critical vaccines. ๐๐ฎ๐๐ถ๐๐๐ฟ๐ฒ by IIL is the only indigenous Hep A vaccine, currently available in India.
The award was received on behalf of the company by ๐ฆ๐ฎ๐ฟ๐๐ต๐ฎ๐ธ ๐ฉ๐ฎ๐๐๐ฑ๐ฒ๐๐ฎ, ๐ฆ๐ฟ. ๐ฉ๐ถ๐ฐ๐ฒ ๐ฃ๐ฟ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐; ๐๐ฟ. ๐ฃ๐ฟ๐ฎ๐ฑ๐ฒ๐ฒ๐ฝ ๐๐๐ฝ๐๐ฎ, ๐ฉ๐ถ๐ฐ๐ฒ ๐ฃ๐ฟ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐; ๐ฎ๐ป๐ฑ ๐๐ท๐ฎ๐ ๐ฆ๐ฎ๐ถ๐ป๐ถ, ๐๐ฒ๐ฝ๐๐๐ ๐๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐น ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐ฟ, from the Honโble Minister for IT, Electronics & Communications, Industries & Commerce and Legislative Affairs, Government of Telangana, ๐ฆ๐ต๐ฟ๐ถ ๐. ๐ฆ๐ฟ๐ถ๐ฑ๐ต๐ฎ๐ฟ ๐๐ฎ๐ฏ๐.
This milestone is a testament to the relentless efforts of our teams, our strong culture of innovation, and the trust of our partners worldwide.
At IIL, we remain committed to shaping global healthcare through science-driven innovation and creating a meaningful impact.
#FTCCI #ExcellenceAwards #Innovation #Healthcare #Vaccines #IIL #OneHealth #Hyderabad #ProudMoment
It was a โFeel Goodโ moment to donate Rs.40,00,000 as a part of Corporate Social Responsibility (CSR) to one of Indiaโs premier research institutes, Indian Institute of Science (IISc) in Bengaluru today. The cheque was presented by our Managing Director Dr.K.Anand Kumar to the Director of this prestigious institute Professor Dr. Govindan Rangarajan in the presence of many scientists, including Prof Usha Vijayaraghavan, Dean of Biological Sciences, Prof Sundar Swaminarayan, Chair, Department of Nephrology, Prof KJ Vinoy, Chair, ODAA, Prof Siddharth Jhunjhunwala, Department of Bioengineering and Dr.Pradeep Gupta, Head of R&D at Indian Immunologicals ltd.
Our ability to balance beautifully between making money (Profits) and Social Good is having a profound impact of our business and the respectability earned as a result.
IIL and IISc have worked together on the development of vaccines and one such product Elovac B (recombinant hepatitis B vaccine) has significantly provided affordability to our Universal Immunisation Programme run by the Ministry of Health and Family Welfare, Government of India. What once was a Rs.1000 Hep B vaccine in the 90s sold by a multinational is now made available in India for Rs.10.
Other areas of collaboration were discussed between the two groups.
@iiscbangalore@NDDB_Coop
#IIL #NDDB #OneHealth #CSR
Dr. Naresh Pal Gangwar, IAS, Secretary to Government of India, Department of Animal Husbandry Dairying and Fisheries visited Indian Immunologicals Limited in Gachibowli Hyderabad. Dr K Anand Kumar, Managing Director IIL took him on a tour of IILโs world class vaccine facility and briefed about the work that IIL does and itโs achievement of being the single largest contributor to vaccine security of the nation and also offering affordable vaccines to more than 60 countries. Honโble Secretary Shri Gangwar was appreciative of the facility and itโs up keep.
Dr. Santhosh Ghadage, DMD, and many senior officials were present on the occasion.
@NDDB_Coop@Dept_of_AHD
#OneHealth #MakeInIndia #IIL #NDDB
Across generations, one truth has remained constant: vaccines save lives.
They protect every age, every stage, every generation โ and they safeguard animals that support livelihoods and share our world.
At Indian Immunologicals Limited, we believe in One Health โ where protecting humans and animals together builds stronger, healthier communities.
For every child. Every family. Every future.
This World Immunization Week, letโs reaffirm a simple truth: for every generation, vaccines work.
#WorldImmunizationWeek #VaccinesWork #OneHealth #IndianImmunologicals #Immunization #PublicHealth #AnimalHealth #vaccines #VaccinationAwareness #PreventiveHealthcare #HealthyCommunities #GlobalHealth #StrongerTogether #HealthForAll #DiseasePrevention #FutureReady #LivestockHealth #CommunityWellbeing #ScienceForHealth #ProtectEveryGeneration
Today was a momentous occasion as our company celebrated its highest turnover of Rs.1586 Cr for the year 2025-26. To grace the occasion we had with us a well respected Industry leader Shri G.V.Prasad, Co-Chairman and Managing Director of Dr.Reddyโs Laboratories Ltd (@drreddys). In the past decade IIL contributing significantly to One Health has achieved a CAGR of 16%.
Speaking on the occasion and addressing our senior employees our MD Dr.K.Anand Kumar said โToday I stand before you with immense pride and gratitude. Achievement of the companyโs highest turnover in history is not just a milestone but a testament to your dedication, resilience and unwavering commitment to our mission. We are not just a business, our ability to balance profits with social good has earned us achieve cult status. Governments, healthcare practitioners, patients, farmers are placing more trust on us and we need to rise to the occasion through integrity, innovation and excellence. The success is a result of the long hours in the R&D lab, precision in the production floors, tireless efforts by our sales team and the seamless coordination between all functions. Let us also on this occasion renew our committnent to push the boundaries of science, offer availability and affordability, maintain the high standards of quality and indulge in responsible manufacturing."
Speaking on the occasion G.V.Prasad said โ IIL and DRL share many parallels and are driven by common purpose to significantly improve health. I compliment IIL for contributing in the area of One Health. The efficiency with which IIL operates and the frugal innovation adopted has significantly contributed to its bottom line. It is amazing that the company is able to provide life saving vaccines at very affordable prices. I congratulate the entire team at IIL for serving the nation and wish it continued successโ.
Later both the leaders along with Dr. Santhosh Ghadage Deputy Managing Director cut a cake in the midst of thunderous claps by our employees. Subsequently the leaders participated in a Q&A session answering to intelligent questions posed by our staff.
@NDDB_Coop
#IIL #NDDB #OneHealth
Our company was represented at the World Vaccine Congress in Washington, USA by Dr.K.Anand Kumar, MD, IIL and Sarthak Vasudeva, Sr.Vice President, International business. The event provided an opportunity to interact with many across the globe from Academia, Industry, Finance and Regulatory. IIL has collaboration with the leading academic institutions across the globe and also exports its products to over 60 countries earning valuable foreign exchange for our country.
Dr.K.Anand Kumar also participated in a panel โTranslating Public R&D into Animal Health Innovationโ moderated by Dr.Karyn Havas, National Program Leader for Animal Health at USDA. Other members of the panel were Dr.Alan Young, CTO Medgene, Dr.Paul Lawrence, Director, R&D at Bimeda, Dr.Perot, computational biologist at USDA and Dr.Elizabeth Rieder, Senior Research Scientist at USDA.
On the sidelines, Dr.Kumar also met Dr.Mahesh Kumar, Sr.Vice President, Zoetis, and presented a signed copy of his recently launched book โRoad to Anandโ.
@NDDB_Coop
#IIL #NDDB #OneHealth
๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ถ๐ฏ๐น๐ฒ ๐บ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด ๐ฎ๐ ๐๐๐.
No longer are companies respected solely on the top line revenues or bottom line profits. Investors, regulators, customers, employees, prospective employees and the common public hold in high esteem a company for its responsible approach towards the environment, social and governance (ESG).
Just because we make life saving vaccines is no excuse to deplete our natural valuable resources in the name of manufacturing.
It is a remarkable day at IIL today, as we have adopted greener and more sustainable solutions, in the presence of ๐๐ฟ. ๐ ๐๐ป๐ฎ๐ป๐ฑ ๐๐๐บ๐ฎ๐ฟ, ๐ ๐ฎ๐ป๐ฎ๐ด๐ถ๐ป๐ด ๐๐ถ๐ฟ๐ฒ๐ฐ๐๐ผ๐ฟ, ๐๐๐.
๐ฃ๐ถ๐ฝ๐ฒ๐ฑ ๐ก๐ฎ๐๐๐ฟ๐ฎ๐น ๐๐ฎ๐ ๐ณ๐ผ๐ฟ ๐๐ผ๐ถ๐น๐ฒ๐ฟ๐ ๐ฎ๐ ๐๐ฎ๐ฐ๐ต๐ถ๐ฏ๐ผ๐๐น๐ถ:
The introduction of PNG as an alternative fuel to High Speed Diesel (HSD) marks a significant step toward our organizationโs sustainability goals and alignment with Nationally Determined Contributions (NDC) for reducing greenhouse gas emissions. By transitioning from fossil fuels HSD to PNG, we aim to enhance fuel efficiency, reduce environmental impact and promote clean energy usage across our operations.
The adoption of PNG as boiler fuel is expected to reduce our carbon emissions by 2200 tCO2e/annum and annual cost savings of approximately 20โ25% through cleaner combustion and lower emissions from Boiler.
Additionally, PNG eliminates the need for fuel storage and handling logistics, improving safety and operational efficiency.
๐๐ป๐๐๐ฎ๐น๐น๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐ฆ๐ผ๐น๐ฎ๐ฟ ๐ฃ๐ผ๐๐ฒ๐ฟ ๐ฃ๐น๐ฎ๐ป๐ ๐ฎ๐ ๐๐ฎ๐ฐ๐ต๐ถ๐ฏ๐ผ๐๐น๐ถ:
We have installed a ground-mounted captive solar power plant at Gachibowli site marking a major step towards renewable energy adoption and sustainable practices.
The 999.6 kW solar PV system, built with 1680 bifacial modules (595 Wp) and integrated with Rapid Shutdown Protection System (RPS), enhances energy efficiency and ensures high safety standards.
This initiative generates approximately 1.4 million units annually, reduces grid dependency, and contributes to an estimated reduction in carbon emissions by ~1,000 tCO2e/annum.
Kudos to IILโs ever strong Engineering team ably led by Magesh Kumar for the above initiatives.
@NDDB_Coop
#Sustainability #ESG #ResponsibleManufacturing #GreenInitiatives #SustainableFuture #ClimateAction #Decarbonization #NetZero #EnvironmentalResponsibility #CleanEnergy #RenewableEnergy #SolarEnergy #EnergyTransition #GreenEnergy #CarbonReduction #SustainableOperations #EnergyEfficiency
ASPIRE-BioNEST Signs Strategic MoU with Indian Immunologicals Ltd. to Advance One Health Innovation.
ASPIRE-BioNEST, a premier life sciences incubation center at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.
As part of this engagement, Dr.K.Anand Kumar visited ASPIRE-BioNEST and interacted with incubated startups, sharing insights on product development, regulatory pathways, and scale-up strategies, thereby providing startups with valuable industry perspective.
The MoU was signed and exchanged between Dr.K.Anand Kumar, Managing Director, Indian Immunologicals Ltd., and Prof. S. Rajagopal, Director, ASPIRE-BioNEST, in the presence of Dr. D. Yogeswara Rao, Director, ASPIRE; Prof. P. Reddanna, Former Director, ASPIRE; Dr. Anil Kondreddy, CEO, ASPIRE-BioNEST; Dr. Ramakrishna, CEO, ASPIRE-TBI; Mr. Prasad Sreeramakavacham, Vice President โ Finance, Indian Immunologicals Ltd.; Dr. Pradeep Kumar, Head โ R&D, Indian Immunologicals Ltd along with other officials from both organizations.
This partnership represents an important step towards strengthening Indiaโs biotechnology innovation ecosystem, with a strong emphasis on integrated human, animal, and environmental health under the One Health framework.
Under the MoU, startups will benefit from IILโs technical mentorship and domain expertise, along with accessโon a mutually agreed basisโto advanced process development and analytical facilities, including capabilities relevant to viral and bacterial vaccine development. Opportunities to leverage IILโs CDMO capabilities for scale-up and manufacturing readiness will also be explored.
Dr.K.Anand Kumar stated that Indian Immunologicals Ltd. will actively support startups at ASPIRE-BioNEST by extending its full spectrum of expertise across the product development lifecycleโfrom early-stage research and validation to scale-up, regulatory pathways, and commercialization.
@NDDB_Coop
#IIL #NDDB #OneHealth
๐ ๐ฒ๐ฒ๐ ๐๐๐ ๐ฎ๐ ๐ช๐ผ๐ฟ๐น๐ฑ ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ (๐ช๐ฎ๐๐ต๐ถ๐ป๐ด๐๐ผ๐ป, ๐จ๐ฆ๐)
Weโre excited to share that ๐๐๐ ๐๐ถ๐น๐น ๐ฏ๐ฒ ๐ฒ๐ ๐ต๐ถ๐ฏ๐ถ๐๐ถ๐ป๐ด ๐ฎ๐ ๐๐ต๐ฒ ๐ช๐ผ๐ฟ๐น๐ฑ ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ ๐ถ๐ป ๐ช๐ฎ๐๐ต๐ถ๐ป๐ด๐๐ผ๐ป, ๐จ๐ฆ๐ ๐ฎ๐ ๐๐ต๐ฒ ๐๐ป๐ฑ๐ถ๐ฎ ๐ฃ๐ฎ๐๐ถ๐น๐น๐ถ๐ผ๐ป. โ connecting with thriving vaccine industry key stakeholders.
Our Managing Director ๐๐ฟ ๐๐ป๐ฎ๐ป๐ฑ ๐๐๐บ๐ฎ๐ฟ and Sr Vice President - International Business, ๐ฆ๐ฎ๐ฟ๐๐ต๐ฎ๐ธ ๐ฉ๐ฎ๐๐๐ฑ๐ฒ๐๐ฎ shall be representing the company at the event.
Our ๐ ๐, ๐๐ฟ ๐๐ป๐ฎ๐ป๐ฑ ๐๐๐บ๐ฎ๐ฟ will be part of the panel discussion on โ๐ง๐ฟ๐ฎ๐ป๐๐น๐ฎ๐๐ถ๐ป๐ด ๐ฃ๐๐ฏ๐น๐ถ๐ฐ ๐ฅ&๐ ๐ถ๐ป๐๐ผ ๐๐ป๐ถ๐บ๐ฎ๐น ๐๐ฒ๐ฎ๐น๐๐ต ๐๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป.โ ๐ผ๐ป ๐ญ๐๐ ๐๐ฝ๐ฟ'๐ฎ๐ฒ.
If youโre attending WVC and exploring collaboration opportunities, weโd love to connect. Companies can reach out to IIL to:
๐ฎ) ๐๐ผ๐น๐น๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ถ๐๐ฒ ๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ & ๐น๐ถ๐ฐ๐ฒ๐ป๐๐ถ๐ป๐ด
Discuss ๐ฒ๐ฎ๐ฟ๐น๐-๐๐๐ฎ๐ด๐ฒ ๐ฐ๐ฎ๐ป๐ฑ๐ถ๐ฑ๐ฎ๐๐ฒ๐ for ๐ฐ๐ผ-๐ฑ๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ and ๐น๐ถ๐ฐ๐ฒ๐ป๐๐ถ๐ป๐ด pathways.
๐ฏ) ๐๐ผ๐ป๐๐ฟ๐ฎ๐ฐ๐ ๐บ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด ๐ฝ๐ฎ๐ฟ๐๐ป๐ฒ๐ฟ๐๐ต๐ถ๐ฝ๐
Leverage IILโs ๐๐ฐ๐ฎ๐น๐ฒ ๐ผ๐ณ ๐บ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด, ๐ฐ๐ผ๐๐ ๐ฐ๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ๐ป๐ฒ๐๐, ๐ผ๐ฝ๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฒ๐ณ๐ณ๐ถ๐ฐ๐ถ๐ฒ๐ป๐ฐ๐, ๐ฎ๐ป๐ฑ ๐๐๐ฟ๐ผ๐ป๐ด ๐ฟ๐ฒ๐ด๐๐น๐ฎ๐๐ผ๐ฟ๐ ๐ฐ๐ผ๐บ๐ฝ๐น๐ถ๐ฎ๐ป๐ฐ๐ฒโespecially where these strengths create a compelling case for your candidateโs manufacturing strategy.
๐ฐ) ๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น ๐ฟ๐ฒ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ฝ๐ฝ๐ผ๐ฟ๐๐๐ป๐ถ๐๐ถ๐ฒ๐
Explore partnerships for ๐ฟ๐ฒ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ถ๐ป๐ด ๐๐๐โ๐ ๐ฐ๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น๐น๐ ๐ฎ๐๐ฎ๐ถ๐น๐ฎ๐ฏ๐น๐ฒ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ๐ in relevant markets.
#WorldVaccineCongress #HumanHealth #AnimalHealth #Vaccines #Licensing #CDMO #Biomanufacturing
Our MD, Dr. Anand Kumar hosted Shri. Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare (@MoHFW_INDIA), Government of India and Chairman, HLL Biotech Ltd at our Gachibowli manufacturing facility. Senior officials from both sides discussed about possible collaborative opportunities in the field of vaccine.
It is pertinent to note that IIL has been a trusted and one of the largest supplier of human vaccines to the Universal Immunization Programme (UIP) run by Government of India for many years. Pentavalent vaccine, Measles-Rubella vaccine, DTP vaccine, Recombinant Hepatitis B vaccine are some of the major vaccines supplied. We are fortunate to live in a country wherein our Government procures life saving vaccines and provides it to all citizens free of cost.
@NDDB_Coop
Road to Anand: Reflections of a Contented Soul - written by Dr. K. Anand Kumar.
The book explores themes of resilience, leadership, purpose, and the pursuit of inner contentment, encouraging readersโespecially young leadersโto view adversity as a catalyst for growth and meaningful success.
Chapter 26 of the book: Not longing for long hours
Click on the link to read the news article by Express Pharma: https://t.co/VlKQ7TUTOA
It is with pride to let know that our Managing Director, Dr.K.Anand Kumar has been conferred with the Dr.Verghese Kurien Memorial Award and Citation by Pt.Deen Dayal Upadhayaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan, Mathura. The award was presented by Dr. Abhijit Mitra, Vice Chancellor of esteemed University in the presence of Deans of various institutions, staff and several hundred students from the disciplines of veterinary sciences, fishery sciences, biotechnology etc.
Dr. Kumar spoke about the Visionary leader Dr.Kurien who decades ago addressed the top three goals of the modern SDGs, No poverty, Zero hunger, Good health and Well being. All this through creation of many institutions of importance including the creation of IIL in 1982.
@NDDB_Coop
Proud to share that Indian Immunologicals Ltd is exhibiting at World Vaccine Congress Washington 2026 on 30 March โ 2 April.
This event brings together decision-makers, innovators, and solution providers shaping the future of vaccines.
Join us in Washington. Extra 25% off with code SBEXH25 + 20% early-bird discount until 6 March.
๐ Register now:
https://t.co/iDrxbLgseT
๐ฅ๐ฒ๐ฎ๐ฐ๐ต ๐ผ๐๐ ๐๐ผ ๐๐ ๐๐๐ง๐ฉ๐๐๐ ๐๐๐จ๐ช๐๐๐ซ๐ ๐ผ๐ฟ ๐ฟ๐ง.๐.๐ผ๐ฃ๐๐ฃ๐ ๐๐ช๐ข๐๐ง ๐๐ผ ๐๐ฐ๐ต๐ฒ๐ฑ๐๐น๐ฒ ๐ฎ ๐บ๐ฒ๐ฒ๐๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐ฑ๐ถ๐๐ฐ๐ผ๐๐ฒ๐ฟ ๐ฐ๐ผ๐น๐น๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ถ๐๐ฒ ๐ผ๐ฝ๐ฝ๐ผ๐ฟ๐๐๐ป๐ถ๐๐ถ๐ฒ๐. ๐ช๐ฒ ๐ฎ๐ฟ๐ฒ @ ๐ฝ๐ค๐ค๐ฉ๐: 323
#WVCDC #WorldVaccineCongress #OneHealth #IIL #IndianImmunologicals #ContractManufacturing #ContractDevelopment